Novartis AG

NVS · SWISS

$151.12−$5.15 (−3.30%)TodayMarket closed · Oct 23, 7:30 PM ET

Prev close $156.27

About NVS

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. The company is headquartered in Basel, Basel-Stadt and currently employs 75,267 full-time employees. The company went IPO on 2001-05-07. The firm develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The firm uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Employees: 75,267
Headquarters: Basel, Basel-Stadt
Listed: May 7, 2001
Sector: Health Care
Industry: Pharmaceuticals
Website: novartis.com

Leadership

Novartis AG executives
Name	Title	Since	Age
Giovanni Caforio	—	2025	61
Vasant Narasimhan	—	—	49
Simon Moroney	—	—	66
Harry Kirsch	—	—	60
Shreeram Aradhye	—	—	63
Victor Bulto	—	—	47
Patrick Horber	—	—	55
Steffen Lang	—	—	58
Fiona Marshall	—	—	61
Klaus Moosmayer	—	—	57
Aaron Gal	—	—	59
Karen Hale	—	—	57
Charlotte Pamer- Wieser	—	—	—
Patrice Bula	—	—	69
Elizabeth Mcnally	—	—	64
Nancy Andrews	—	—	67
Ton Buechner	—	—	60
Dna. Ana de Pro Gonzalo	—	—	58
Elizabeth Doherty	—	—	68
Bridgette Heller	—	—	64
Daniel Hochstrasser	—	—	65
Frans van Houten	—	—	65
John Young	—	—	61

Similar companies

Companies in the same industry as Novartis AG

OCSOculis Holding AG$7.90−2.35%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.